BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:44 PM
Feb 01, 2007
 |  BC Extra  |  Financial News

Celgene reports earnings

CELG posted fourth quarter 2006 adjusted diluted EPS of $0.18, meeting the Street's estimate and up from $0.03 in 4Q05. Fourth quarter revenues increased 84% to $275 million, including $123.8 million in sales of Revlimid and $110.2 million in sales of Thalomid. In...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >